Introduction
It is generally accepted that saliva is of paramount importance for the maintenance of oral health. This is based on the numerous studies reporting subjective and objective functional losses that occur in persons who lack the ability to produce adequate volumes of saliva. These include dry mouth feeling (xerostomia), diculty with swallowing food, and an increased susceptibility for opportunistic infections. The last issue points to an active protective role of saliva in maintaining oral health under normal conditions. The mild climate present in the oral cavity, i.e. an elevated temperature, a high humidity and regular supply of foodstus, fosters the growth of a myriad of dierent aerobic and anaerobic microorganisms, which together form a complex and stable ecosystem. For example, the oral mucosal surfaces of the newborn infant are the portal of entry for the majority of pathogenic microorganisms from the ®rst day of life (Seidel et al, 2001) . Saliva plays a key role in maintaining the steady-state of this system, as becomes clear when the salivary clearing is blocked, for instance in sedated patients in intensive care. In the majority of these patients within 2 weeks a shift in the oral micro¯ora occurs to Gram-negative species, which subsequently spread into the respiratory tract causing pulmonary aictions. This is one example of the crucial role played by saliva in the maintenance of general health, but similar observations can be made in other patients suering from an impaired saliva secretion. It is recognized for years that saliva contains many components that, in one way or another interact with microorganisms, in this way controlling the composition of the oral micro¯ora. In the seventies and eighties of the previous century, the main proteins and peptides in human saliva have been identi®ed and characterized (see Figure 1 ). Still for a lot of proteins the precise biological role remained elusive as translation of biochemical properties to biological functions proved to be dicult or resulted in erroneous concepts. In the seventies, research focused on elucidation of the role played by saliva in the protection of dental enamel and identi®ed a large number of proteins that in vitro were involved in the formation of pellicles on hydroxyapatite. Henceforth they were attributed a role in the protection of tooth surfaces. The insight that a lot of so-called saliva-speci®c or pellicle-speci®c proteins also were present in other parts of the human body has stimulated further investigation to the biological role in the innate protection of mucous oral epithelia (Schenkels, Veerman and Nieuw Amerongen, 1995b) . As a consequence, for some salivary proteins the existing concepts were re®ned, while for others a completely dierent role was found, e.g. as microbicidal agents, or as physiological inhibitors of proteinases.
In earlier days the immunoglobulins in saliva have received much attention in relation to their speci®c protective function to a single type of microorganism. However, nowadays it has become more clear that, in addition to this acquired immune system, also an innate immune system has been secreted into saliva. In the last years more light has been shed on the protective functions of the peptides and of the (glyco)proteins of the innate immune system, contributing to the ®rst line of oral defence (Frohm Nilsson et al, 1999) . In addition, recent research on bacteriostatic (glyco)proteins revealed that they have hidden domains possessing microbicidic properties that come available after proteolysis. Although it appears at ®rst glance on Figure 1 that a redundance to defence mechanisms in saliva is present (Rudney, Hickey and Ji, 1999) , this has been suggested only by in vitro studies. In vivo it is clear that the inhibiting and killing eects are regulated precisely so that an ecology exists in an equilibrium system in the oral cavity.
This mini-review, primarily dealing with the defensive systems in saliva, will in particular focus on the more recently obtained data, aiming to (re)interpret earlier observations on the basis of our present knowledge. In this respect it is intended to give an update of the current knowledge and insights in the protective role of salivary components.
Blood group active glycoproteins: mucins and salivary agglutinin
Salivary mucins
The earliest studies on salivary mucins concluded that these glycoproteins occurred as a single high molecular weight species containing blood group activity (Milne and Dawes, 1973) . Later studies, using more stringent isolation and analytical techniques demonstrated that human saliva contains two genetically distinct mucin types, designated MG1 and MG2 (Levine et al, 1987; Nieuw Amerongen, Bolscher and Veerman, 1995; Tabak 1995) , originating from the MUC5B and MUC7 gene, respectively (Bobek et al, 1993; Desseyn et al, 1997) . MUC7 (MG2) has been found to exist as at least two glycoforms, MG2a and MG2b, respectively (Biesbrock, Bobek and Levine, 1997) . In addition, genetic polymorphism has been shown for MUC7, which is associated with asthma (Kirkbride et al, 2001) . Salivary MUC5B (MG1), which displays blood group activity, exists in at least three dierent glycoforms, diering in sialic acid and sulphate content, depending on the glandular source (Veerman et al, 1992; Bolscher et al, 1995) . Even within one glandular secretion, dierent MUC5B glycoforms could be distinguished (Veerman et al, 1992 Bolscher et al, 1995; Thornton et al, 1999) , highlighting the extreme inter-and intramolecular heterogeneity of this class of salivary glycoproteins. MUC5B functionally and structurally belongs to the classical mucins, which are the main constituents of the slime layers that cover the mucous epithelia throughout the body, e.g. in the gastrointestinal tract, the urogenitary tracts, and the respiratory tracts. These secretory mucins, although encompassing a genetically heterogeneous family, have a comparable architecture: they are composed of disulphide linked monomers that contain heavily glycosylated domains, interspersed with less glycosylated peptide domains (`naked' peptides). Because of their high carbohydrate content (>80%), their large dimensions (>1 lm), and their extended thread-like structure, the classical secretory Figure 1 Schematic presentation of the main functions of saliva in relation to its constituents Saliva ± the defender of the oral cavity AV Nieuw Amerongen and ECI Veerman mucins already at low concentrations form hydrophilic viscoelastic gels. These gels function as barriers, protecting the underlying epithelium against mechanical damage and preventing direct entrance of noxious agents, including bacteria and viruses, into the underlying vulnerable epithelium. In the oral cavity, MUC5B is present in the protein ®lms (pellicles) covering the enamel and epithelial surfaces, and in this quality protect against acidic attacks (Nieuw Amerongen, Oderkerk and Driessen, 1987) and modulate the microbial colonization of these surfaces (Table 1) .
Besides in the mucous acini of the (sero)mucous salivary glands (submandibular, sublingual, palatal and labial glands), MUC5B is also expressed in other body tissues, including the submucosal tracheobronchial glands, the gall bladder and the endocervix (Gipson et al, 1997; Sharma et al, 1998; Van Klinken et al, 1998) . In contrast, the expression of MUC7 is con®ned largely to the serous cells of the (sero)mucous salivary glands and of the respiratory tracts (Biesbrock et al, 1997; Nielsen et al, 1997; Sharma et al, 1998; Bolscher et al, 1999) . MUC7 and MUC5B are structurally and functionally completely dierent molecules. MUC7 is a relatively small (Mr 125 kDa) monomeric species, having low viscoelastic properties. The carbohydrate side chains of MUC7 are predominantly sialylated di-and trisaccharides, while those in MUC5B are much more heterogeneous, with sizes that may vary between two and >20 residues. Furthermore, in contrast to MUC5B, MUC7 lacks blood group active carbohydrates of the ABO-system, a feature that was considered a characteristic trait of mucins (Prakobphol et al, 1998) .
When in vitro tested, preparations containing high molecular weight blood group reactive glycoproteins cause a wide variety of oral microorganisms to agglutinate, highlighting binding of these components with bacterial receptors. Extrapolated to in vivo situations, it is tempting to speculate that this is a physiological mechanism for clearing, to diminish overload of bacteria. It has become clear now that MUC7 and the salivary agglutinin (see below) are among the major bacteria-agglutinating factors in saliva. Several studies have reported binding of MUC7 to a variety of microorganisms, e.g. Streptococcus sanguis, S. mitis, S. gordonii, Actinobacillus actinomycetemcomitans, Pseudomonas aeruginosa and Escherichia coli (Murray et al, 1992; Reddy and Levine, 1993; Groenink et al, 1996; Moshier, Reddy and Scannapieco, 1996) . In addition to carbohydrate residues, e.g. sialic acid (Reddy et al, 1993; Groenink et al, 1996) , unglycosylated peptide domains in MUC7 are involved in the interaction with bacteria (Moshier et al, 1996; Liu et al, 1999; Groenink et al, 1999b) . Interestingly, the histidinrich N-terminal peptide domain of MUC7, which encompasses residues 23±37, by itself has bactericidal properties, probably because it is able to bind and disturb the bacterial membranes (Liu et al, 2000; Situ and Bobek, 2000) .
Studies aimed at identi®cation of species speci®cally binding to (isolated) MUC5B preparations have demonstrated only few species capable of binding to this mucin, including Haemophilus parain¯uenzae and Helicobacter pylori Bosch et al, 2000) , whereas other species, including Streptococci do not bind (Murray et al, 1992) .
Agglutinin
Salivary agglutinin is a highly glycosylated protein, with a molecular mass of approximately 340 kDa, that carries blood group active antigens. Except for the presence of blood group antigens, salivary agglutinin, which is identical to gp-340 expressed in lung (Holmskov et al, 1999; Prakobphol et al, 2000; Ligtenberg, Veerman and Nieuw Amerongen, 2001 ) shares a number of features with MUC7: both are monomeric, heavily glycosylated proteins, with extremely sticky properties. As a consequence, under native conditions these proteins occur associated with a variety of salivary proteins, including S-IgA (Biesbrock, Reddy and Levine, 1991; Mehrotra, Thornton and Sheehan, 1998) . Both MUC7 and salivary agglutinin are expressed in the serous cells of the submandibular, sublingual and labial glands (Sharma et al, 1998; Bikker et al, 2002) . However, agglutinin, in contrast to MUC7, is also synthesized in the serous parotid gland. In the parotid gland agglutinin was localized only in the ductal cells, whereas in the submandibular gland agglutin was detected in both serous acinar cells and serous demilune cells capping the mucous acini (Bikker et al, 2002) . Agglutinin, initially identi®ed as the protein responsible for the S. mutans aggregating properties of parotid saliva (Ericson and Rundegren, 1983) , was later found to mediate also the binding between S. mutans and S. sanguis (Lamont et al, 1991) . This salivary glycoprotein, which very likely is identical to the Eikenella aggregating factor (EcAF) isolated by Ebisu, Fukuhara and Okada (1988) , is also detectable as a component of the salivary pellicle on the tooth surface (CarleÂ n and Olsson, 1995) . It now has become clear that agglutinin, like MUC7, binds to a wide variety of microorganisms, including S. mutans, S. salivarius and S. sanguis . Evidence has been produced that salivary agglutinin is genetically very similar, if not identical, to gp-340, a glycoprotein present in lung washings (Prakobphol et al, 2000; Ligtenberg et al, 2001) . Gp-340 binds to surfactant protein-D, resulting in enhanced phagocytosis and killing of microorganisms by neutrophils and macrophages (Holmskov et al, 1999) . Gp-340 is also identical to DMBT-1 (protein Deleted in Malignant Brain Tumours), a member of the scavenger receptor family, a group of proteins that, because of their capacity to bind to a broad variety of ligands, has been implicated in the innate immune system (Mollenhauer et al, 2000) .
Cystatins: cysteine proteinase inhibitors
In the eighties it became apparent that a group of human salivary proteins, which initially were implicated in the control of mineralization, possesses cysteine proteinase inhibitory activity (Shomers et al, 1982) . On basis of sequence homology these proteins have been classi®ed as members of family 2 cystatins. In saliva at least nine dierent cystatin isoforms are secreted, including the neutral cystatin SN, three moderately anionic isoforms of cystatin SA, three or four isoforms of the more anionic cystatin S and cystatin C, a cationic cystatin (Henskens, Veerman and Nieuw Amerongen, 1996; Tseng et al, 2000) .
More recently the presence of cystatin D has also been demonstrated in human saliva (Hall et al, 1998) . Because of their proteinase inhibiting properties, cystatins have been suggested to play a role in controlling proteolytic activity, either from the host (released during in¯ammatory processes) or from microorganisms (Blankenvoorde et al, 1996) . However, there is experimental evidence suggesting that cystatin C, although a minor constituent of the total population of oral cystatins, contributes most to the cysteine proteinase inhibiting activity of saliva . This is corroborated by kinetic studies showing that of all salivary cystatins, cystatin C displays the most avid inhibition of model cysteine proteinases, e.g. cathepsins and papain. Both egg-white cystatin and cystatin S can inhibit partially proteolytic enzymes released in P. gingivalis culture medium (Blankenvoorde et al, 1996) . In addition, these proteins inhibit growth of speci®cally P. gingivalis, but this activity appeared not to be linked to their enzyme-inhibiting properties (Blankenvoorde et al, 1998) . In rodents, cystatins are absent from saliva under normal conditions but become induced after various treatments, including administration of the b-adrenergic agonist isoproterenol, feeding with tannin-rich food (sorghum), application of papain and turpentin on the oral tissues, or cutting the incisors (Bedi 1991; Chaparro, Yu and Shaw, 1998) . Salivary cystatins are constitutively secreted in humans, but evidence has been produced that in particular cystatin C levels are increased following severe in¯ammation in periodontal diseases (Henskens et al, 1994) . A putative role of cystatins in mediating in¯ammatory responses is suggested by data demonstrating that in vitro family 2 cystatins can up-regulate cytokine production in gingival ®broblasts, a process which probably does not involve its proteinase inhibitory site .
Von Ebner glands protein (VEGh) and secretory leucocyte proteinase inhibitor (SLPI)
VEGh, as a cysteine proteinase inhibitor VEGh is a salivary protein secreted by the Von Ebner glands located around the circumvallate and foliate papillae of the tongue. It is also known as tear-speci®c prealbumin (TSPA). VEGh belongs to the lipocalin superfamily, the members of which possess very similar structural features, despite a nearly completely absence of sequence homology. Originally it has been assumed that VEGh was involved in the perception of bitter taste by binding lipophilic bitter compounds and transporting them to the taste buds. However, later it was demonstrated that VEGh can act as inhibitor of cysteine proteinases ( Van't Hof et al, 1997) . This activity has been attributed to the presence of an inhibitory domain in its N-terminus, structurally resembling a motif in cystatins that is required for inhibitory activity. Evidence has also been produced that VEGh can act as an oxidative-stress induced scavenger of peroxidation products (Redl et al, 1999; Lechner, Wojnar and Redl, 2001 ). The recent ®nding that tear lipocalin, which is identical to VEGh, possesses endonuclease activity, points to still another function for this protein, as nucleases may act as antiviral agents and inhibit the replication of both DNA and RNA viruses . The ubiquitous presence of VEGh in various secretions, including saliva, tears and semen, would indeed favour a more general role, e.g. as antiviral agent, over tissue-speci®c functions such as a carrier for bitter compounds in saliva, a retinol-binding protein in tear and an androgen-binding protein in semen . It can be speculated that the proteinase-inhibitory activity of VEGh protects the whole molecule against proteolytic inactivation, but is not linked with its main physiological function.
SLPI, inhibitor of serine proteinases
Another example of salivary protein with more than one function is the SLPI (Shugars, Watkins and Cowen, 2001 ). This protein, for the ®rst time isolated from respiratory secretions, is an inhibitor of serineproteinases (designated a serpin), including neutrophil elastase, chymotrypsin and Cathepsin G. Besides in human airway submucosal glands, SLPI is expressed in various secretory tissues, including the submandibular, sublingual, parotid, and minor salivary glands. In addition to its proteinase inhibitory properties, SLPI has antimicrobial and antiviral properties (McNeely et al, 1995) . Interestingly, mice knocked out for the gene encoding SLPI show impaired cutaneous wound healing with increased in¯ammation and elastase activity, pointing to a pivotal role for SLPI in wound healing.
TIMPS: tissue inhibitors of metalloproteinases
In parotid and submandibular secretions TIMP-1 has been identi®ed, a member of the family of tissue inhibitors of matrix metalloproteinases (MMPs) (Hayakawa et al, 1994) . Considering their potent inhibitory action against MMPs, including collagenase, gelatinase and stromelysin, TIMPs are thought to play an important role in turnover and remodelling of the extracellular matrix. In saliva the main type of collagenase derives from the host leucocytes, suggesting a role of salivary TIMP-1 in control of in¯ammatory diseases. Such a function would also be suggested by the ®nding that TIMP levels in saliva of periodontitis patients, which have elevated collagenase activities, are decreased compared with those in healthy controls. However, other unique functions of TIMPs have been reported, including erythroid potentiating activity, cell growth-promoting activity, and stimulation of osteoclastic bone resorption (Murate and Hayakawa 1999) . Interestingly, the latter activity could not be ascribed to merely their inhibitory eect on matrix proteolysis, indicating that TIMPs, like VEGh and SLPI, are multifunctional proteins.
Extra-parotid glycoprotein (EP-GP)
EP-GP is another example of a protein that originally had been implicated in the formation of the dental pellicle, because of its high anity for hydroxyapatite (Rathman et al, 1989) . Later studies demonstrated that EP-GP protein is present in several excretory body¯uids, including sweat, semen and tears, and is identical to secretory actin binding protein (SABP) and Gross Cystic Disease Fluid Protein (GCDFP-15) (Schenkels et al, 1994 , Schenkels, Veerman and Nieuw Amerongen, 1995a , 1995b Caputo et al, 1999) . The ubiquitous presence in mucosal secretions pointed to a more general protective role for EP-GP, a concept that was supported by the observation that this protein binds to microorganisms (Schenkels et al, 1997) as well as to the CD4 receptor on monocytes (Autiero et al, 1997; Gaubin et al, 1999) . New light was shed on its function when evidence was produced that GCDFP-15 is an aspartyl proteinase with a very narrow substrate speci®city: in vitro studies showed that GCDFP-15 hydrolyses gelatine and ®bronectin, but not bovine serum albumin (BSA), laminin, casein, vitronectin and CD4 (Caputo et al, 2000) . GCDFP-15, which under non-pathological conditions is absent from breast tissues, is used as a marker for apocrine carcinoma of the breast and the skin (Caputo et al, 2000) . In view of the expression in malignant tissues, it is speculated that the ®bronectin-degrading activity of GCDFP-15 facilitates cell-invasion by cleaving the extracellular matrix scaold between cells, thus detaching cell membranes from adhesion sites. Under physiological conditions EP-GP might be involved in the turnover of mucous tissues by facilitating the detachment of epithelial cells, but experimental evidence in support of this function is still lacking.
Lactoferrin
The presence of lactoferrin in secretions such as tears, milk and saliva is usually linked with its iron-binding properties. There is general consensus that the longknown bacteriostatic eects of lactoferrin are the result of its iron-depriving eects. In addition, in the nineties it was shown that both bovine and human lactoferrin contain a hidden antimicrobial domain that is liberated from the molecule after proteolytic digestion by pepsin. Within this domain, comprising the 1±47 N-terminal amino acids of human lactoferrin (designated lactoferricin-H), two bacteriocidic fragments can be mapped, residues 1±11 and residues 18±31, respectively (Bellamy et al, 1992; Groenink et al, 1999a; Lupetti et al, 2000) . Despite a high sequence homology between the human and the bovine lactoferrin, the antimicrobial properties of peptides derived from the latter are considerably stronger (Bellamy et al, 1993; Groenink et al, 1999a) . One of the target microorganisms of lactoferrin is the periopathogenic bacterium A. actinomycetemcomitans. It has been reported that in periodontitis patients, carrying A. actinomycetemcomitans, a negative correlation exists between the number of subgingival A. actinomycetemcomitans and the lactoferrin concentration in saliva (Groenink et al, 1999b) . In addition, it inhibits also the growth of Helicobacter pylori in an in vitro culture system and H. felis in an in vivo mouse model (Dial et al, 2000) .
It is conceivable that antimicrobial domains will be released during digestion of lactoferrin in the gastrointestinal tract. This would support the idea that salivary proteins besides the mouth, also can be involved in protection downstream along the gastrointestinal tract. It is now clear that lactoferrin is a multifunctional protein having bacteriostatic, bactericidic, fungicidal, antiviral and anti-in¯ammatory and immunomodulatory properties (Soukka, Tenovuo and Lenander-Lumikari, 1992; Nikawa et al, 1993) .
Antimicrobial enzymes: lactoperoxidase, lysozyme and chitinase Peroxidase activity in saliva is derived from two sources: human salivary lactoperoxidase (HS-LPO) is synthesized and secreted by the salivary glands, whereas myeloperoxidase (MPO) is found in polymorphonuclear (PMN) leucocytes, which migrate into the oral cavity at gingival crevices. Reportedly, the contribution of MPO to the total salivary peroxidase can vary between 30 and 75%, possibly depending on the oral health of the subjects participating (Thomas et al, 1994; Ortiz et al, 1997) . Salivary peroxidases catalyse the formation of bactericidic compounds, e.g. hypothiocyanate, by peroxidation of thiocyanate. Because of the antimicrobial eects of the lactoperoxidase system, dentifrices and mouthrinses have been marketed which enhance the endogenous activity of salivary peroxidase, by supplementing H 2 O 2 -generating enzyme systems.
Lysozyme is ubiquitously present in body¯uids, including saliva, tears, bronchial mucus and sweat (Schenkels et al, 1995b) . The well-known antimicrobial activity of lysozyme is generally linked with its lytic action on bacteria by catalysing the hydrolysis of cell wall polysaccharides. In addition, non-enzymatic bactericidic activity has been documented for lysozyme as well, which has been attributed to activation of bacterial autolysins (Laible and Germaine, 1985) .
Recently, evidence has been produced that chitinase, which catalyses the hydrolytic cleavage of chitin (±GlcNAcb(1±4)GlcNAc±) is not only present in serum, but also in saliva, where it is derived from the parotid, submandibular, sublingual and palatine glands (Van Steijn et al, 1999) . As chitin is a constituent of the yeast cell walls, chitinase activity may play a role in the protection against colonization of oral epithelial cells by yeast. Interestingly, in saliva of periodontal patients, chitinase levels are signi®cantly elevated compared with those in healthy controls (Van Steijn et al, 2002) . After periodontal treatment, a decrease in activity of chitinase was found, suggesting that its expression is regulated by in¯ammatory mediators.
Antimicrobial peptides: histatins and defensins
In the past decennia much attention has been paid to the salivary histatins, a family of structurally related peptides that are enriched in arginine, histidine and lysine residues. In human saliva at least 12 histatin-like peptides have been identi®ed, the majority of which are degradation fragments of two parent molecules, histatin 1 and histatin 3 (Troxler et al, 1990) . Of all histatins, histatin 1, histatin 3 and histatin 5 (which is derived from histatin 3), are most abundant in parotid saliva. Presumably because of its relatively potent fungicidal properties (Oppenheim et al, 1988) , histatin 5 has been subject to numerous studies. Besides killing of bacteria, such as S. mutans (Mackay et al, 1984) and yeasts, histatin 5 has been implicated in a variety of processes, including pellicle formation (Jensen, Lamkin and Oppenheim, 1992) , neutralization of potentially noxious substances, e.g. polyphenols (Yan and Bennick, 1995) , chelation of metal ions (Melino et al, 1999; Gusman et al, 2001a) , inhibition of in¯ammatory cytokine induction , and inhibition of host and bacterial proteinases, including metalloproteinases and cysteine proteinases (Gusman et al, 2001a (Gusman et al, , 2001b . The anity of histatins for such a large repertoire of chemically and structurally dierent ligands obviously is linked to the unique chemical and structural feature of this molecule. For example, histatin 5 molecules have a¯exible structure: in water they have a random-coil structure, while in apolar media they can adopt an a-helical structure. The absence of a strict secondary structure, in addition to the presence of both charged and hydrophobic domains, is probably the key to the multibinding features of histatins, as it will favour binding to structurally and chemically widely dierent molecules. Nevertheless it is still unclear what the main oral function of histatins would be and whether in vivo these are truly multifunctional compounds. Their antimicrobial properties are most appealing and therefore have attracted a lot of interest (Edgerton et al, 1998; Helmerhorst et al, 1999a Helmerhorst et al, , 1999b Helmerhorst et al, , 2001 . Although it was hypothesized that the mechanism of killing activity of cationic peptides was by pore formation in the cellular membrane (Hancock 1997) , there is much evidence that the various cationic peptides may have dierent types of killing mechanisms (Ruissen et al, 2001 ; Van't Hof et al, 2001) . Still it has to be noted that histatin 5, compared with antimicrobial peptides in other parts of the human body, e.g. defensins, in vitro display relatively weak microbicidic properties that are readily abolished at moderately elevated ionic strength.
Recently, b-defensins have also been demonstrated in saliva (Krisanaprakornkit et al, 2000; Dale and Krisanaprakornkit, 2001 ). These antimicrobial peptides, which are induced in epithelial tissues upon in¯amma-tion (Harder et al, 2000) , are also expressed in duct cells of salivary glands. These peptides are part of the innate immune system; they have broad spectrum antibacterial and antifungal activity and they have properties that may serve to link innate immunity with the acquired immune system.
Calprotectin
Calprotectin is a calcium-and zinc-binding protein derived mainly from granulocytes, monocytes and macrophages. It appears to inhibit microbial growth through competition for zinc (Sweet, Denbury and Challacombe, 2001 ). The main sources of salivary calprotectin appear to be the gingival crevicular¯uid and the oral surface epithelium. As the calprotectin concentration rises markedly in some in¯ammatory diseases, this protein has been thought to be a marker of in¯ammatory disease. In periodontitis, calprotectin appears up-regulated and is detected at higher levels in gingival crevicular¯uid and tissue specimens. Furthermore, salivary calprotectin levels are raised in patients with oral candidiasis, consistent with mucosal transudation of calprotectin from in¯amed mucosa (Kleinegger, Stoeckel and Kurago, 2001) .
Chromogranin A Chromogranin A is a major protein in adrenal chroman cells and adrenergic neurones. In the submandibular glands of the rat, chromogranin A-like immunoreactivity is stored in the exocrine cells in the granular convoluted tubule, and is secreted into saliva by stimulation with noradrenaline and acetylcholine. In human, a prompt elevation of salivary chromogranin A-like immunoreactivity is found in psychosomatic stresses (Nakane et al, 1998) . Vasostatin-1, the natural N-terminal 1±76 chromogranin A-derived fragment in bovine sequence, displays antibacterial activity against Gram-positive bacteria at micromolar concentrations and is also able to kill a large variety of ®lamentous fungi and yeast cells (Lugardon et al, 2000) .
Multifunctional salivary proteins
In the past decades the genetics and the biochemical properties of the major salivary proteins and peptides have been unravelled. Furthermore, the functions of a number of proteins have been identi®ed unambiguously. For example, there is general consensus that S-IgA, directed against speci®c microorganisms, plays a role in the immunological defence of body secretions, including saliva. However, under stressful conditions the concentration and the composition of the immunoglobulins can change dramatically (Steerenberg et al, 1997; Bosch et al, 2001) . Similarly, the biological role of other proteins is established with reasonable certainty. Examples are the large salivary mucins (MUC5B), which are primarily responsible for the viscoelastic properties of salivary ®lms, salivary peroxidase, involved in the production of antimicrobial inorganic ions, and amylase, involved in digestion of starch. For a number of other proteins that yet lack a clear (enzymatic) activity the function can only be extrapolated on the basis of characteristic' properties. Although inevitable, such an approach may lead to erroneous concepts, and history has learned that one should exercise caution when claiming functions on the basis of properties alone. So, when on basis of amino acid sequence no clear biological role for an isolated protein can be identi®ed, an often used approach is to study interaction (binding) to various substrates, microorganisms, and proteins, in the hope to gain clues for a biological role. For instance, EP-GP, originally isolated because of its selective adsorption onto hydroxyapatite, was implicated in bacterial clearance when we found it binding to Streptococci, in situ as well as in vitro (Schenkels et al, 1997) . Finally it turned out that GCDFP-15 (which is identical to EP-GP) is a proteinase with a very narrow substrate speci®city, pointing to a role in remodelling of the extracellular matrix (Caputo et al, 2000) . Another example is VEGh which, initially was implicated in taste perception, because of its glandular origin (the Von Ebner glands in the tongue) (Garibotti et al, 1995) .
Later VEGh was shown to inhibit cysteine proteinases, and ®nally it turned out to have endonuclease activity. Another example is the salivary gustin, which because of its zinc-binding properties was linked with taste perception, but now has been identi®ed as a member of the carbonic anhydrase family (Thatcher et al, 1998) . In this context the term multifunctionality has been coined to indicate the phenomenon that one salivary protein may exert dierent functions. However, from the foregoing it will be clear that it is not easy to tell whether a property of a protein is linked with its main physiological function, whether it assists in the main physiological function, or is a pure coincidence. For instance salivary histatin 5, the strongest antimicrobial histatin species, contains a zinc-binding motif (Melino et al, 1999) and is able to bind copper ions as well (Gusman et al, 2001a (Gusman et al, , 2001b . The capability to bind metal ions suggests a scavenger role for detoxi®cation of metal ions in the oral cavity, a function not related to its putative antimicrobial function. On the other hand, upon binding to zinc, histatin 5 adapts the a-helix conformation, which is pivotal to its antimicrobial activity. In the latter case zinc might be considered as a cofactor, enhancing the antimicrobial function. Because of their polyphenol binding properties, histatins have also been implicated in the detoxi®cation of dietary tannins, a function already attributed to proline-rich proteins (PRPs). However, a characteristic feature of antimicrobial peptides, including histatins, is the presence of distinct cationic and hydrophobic motifs. The latter will have a natural tendency to bind to apolar compounds via hydrophobic interactions. Thus it remains to be demonstrated whether binding to polyphenols indeed is physiologically relevant in case of the histatins, or is a mere side-eect of the structural characteristics linked with its main (antimicrobial?) function.
Making statements about the`real' function of a given salivary protein is further hindered by the fact that saliva harbours myriads of dierent microorganisms, some of which may be pathogenic, while others are indierent, or even may be bene®cial for the host. All these species successfully have adapted to survive in an environment that basically strives towards their neutralization and clearance. This makes it dicult to interpret properly data demonstrating binding of salivary proteins to bacteria, as a priori one cannot tell whether such an interaction bene®ts the host or the bacterium. There is little discussion that S-IgA-bacterium binding is an example of an interaction in favour of the host, because of the well-established role of the adaptive immunity in the protection of the body. On the other hand, binding of amylase to certain streptococci (Bergmann and Gulzow 1995) presumably is an example of an interaction that bene®ts the bacterium, as it endows the bacterium with the capability to digest starch (Scannapieco, Torres and Levine, 1995) . Another protein that presumably is abused by microorganisms for their own good is salivary lactoferrin. Because of its iron-depriving eects, lactoferrin is generally considered a bacteriostatic agent. However, a number of pathogens, including Neisseria spp., S. pneumoniae and Haemophilus in¯uenzae, can utilize iron-loaded human lactoferrin as a sole source of iron.
For a number of other proteins it is simply unknown what binding to bacteria means. For instance, EP-GP binding to bacteria, which also can be demonstrated in situ, was ®rst thought to favour microbial clearing. The recent ®ndings that EP-GP speci®cally can hydrolyse extracellular matrix proteins, leaves the possibility open that it might be used as well by microorganisms to enhance in®ltration into the epithelial tissues.
The research in the past decades has produced a wealth of information about the biochemical and functional properties of salivary macromolecules. Figure 1 provides an overview of the functions of saliva, showing that in addition to the same protein having dierent functions, dierent proteins can share the same function. In particular there seems to be an overlap in antimicrobial functions of saliva. This may explain why the protective eects of the secretory antimicrobials amply demonstrated in vitro, are dicult to demonstrate in vivo. Functional overlap will make that no single component is necessary for the overall antimicrobial capacity of the hosts defence system. However, it should be realized that it is dicult to value the signi®cance of defensive and protective systems in saliva. Nowadays in the developed countries there are strict safety-guides for the preparation of foodstu and drinking water, aimed to minimize the risk of food poisoning and microbial contamination. It can be speculated that this will obscure de®cits in the natural protection aorded by innate as well as adaptive immunity, and make it dicult to ®nd signi®cant relationships between the level of a speci®c compound (e.g. S-IgA) and the susceptibility to diseases. Such relationships might become evident in the more`natural' situation, when people are daily exposed to microbial threats by ingestion of contaminated foodstu and drinking water.
Equilibrium in microbial ecology
The oral cavity is colonized by a great number species of microorganisms, varying greatly in quantity. For example, S. oralis and S. sanguis are abundantly present on the surfaces of the teeth, whereas S. mutans forms only a minority of the supragingival plaque (MacPherson, MacFarlane and Stephen, 1991) . That an equilibrium system in microbial ecology exists in the oral cavity can be illustrated by the fact that about half of the population carries Candida albicans without phenomena of candidiasis. In other words, in these cases candidiasis is an opportunistic disease emerging after lowering of the immune system. The equilibrium in the ecology of the microorganisms in the oral cavity will be maintained not only by the diet but also through the interactive inhibition between the bacterial species themselves. An example of the last mechanism is the discovery of the release of Lantibiotics by S. salivarius that can inhibit the growth of S. pyogenes (Upton et al, 2001 ).
Back to the future: from puri®ed compounds towards whole saliva With all the knowledge obtained in the past about the molecular properties of isolated salivary components, it is now time to make a step back and try to understand what their role might be in the complex situation present in vivo. In the mouth¯uid, a number of salivary proteins are not present as single molecular entities, but in complex with the large salivary mucins. It has been speculated that such complexes could enhance or diminish the multiple biological functions of each member of the complex, but this concept still has to be proven (Iontcheva, Oppenheim and Troxler, 1997) . Although it is generally accepted that complexation between salivary macromolecules occurs, and probably in¯uences their biological properties, data about the biochemical and functional properties of these complexes are scarce. One study addressing this issue suggested that binding of MUC7 to S. aureus and P. aeruginosa may involve a MUC7±S-IgA complex (Biesbrock et al, 1991) , but this has to be extended and con®rmed for other microorganisms as well.
